Northern Trust’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.44M | Buy |
1,265,842
+32,157
| +3% | +$132K | ﹤0.01% | 2523 |
|
|
2025
Q4 | $4.16M | Sell |
1,233,685
-107,221
| -8% | -$278K | ﹤0.01% | 2580 |
|
|
2025
Q3 | $1.76M | Buy |
1,340,906
+35,641
| +3% | +$36.9K | ﹤0.01% | 3109 |
|
|
2025
Q2 | $936K | Sell |
1,305,265
-101,269
| -7% | -$79.5K | ﹤0.01% | 3433 |
|
|
2025
Q1 | $2.07M | Sell |
1,406,534
-218,576
| -13% | -$521K | ﹤0.01% | 2909 |
|
|
2024
Q4 | $7.2M | Buy |
1,625,110
+118,962
| +8% | +$483K | ﹤0.01% | 2312 |
|
|
2024
Q3 | $6.21M | Buy |
1,506,148
+29,605
| +2% | +$159K | ﹤0.01% | 2357 |
|
|
2024
Q2 | $9.63M | Sell |
1,476,543
-55,974
| -4% | -$396K | ﹤0.01% | 2021 |
|
|
2024
Q1 | $13.3M | Sell |
1,532,517
-55,875
| -4% | -$678K | ﹤0.01% | 1871 |
|
|
2023
Q4 | $18.2M | Sell |
1,588,392
-53,495
| -3% | -$529K | ﹤0.01% | 1679 |
|
|
2023
Q3 | $15.8M | Buy |
1,641,887
+3,268
| +0.2% | +$32K | ﹤0.01% | 1708 |
|
|
2023
Q2 | $17.4M | Buy |
1,638,619
+74
| +0% | +$795 | ﹤0.01% | 1686 |
|
|
2023
Q1 | $17.2M | Buy |
1,638,545
+7,966
| +0.5% | +$89.2K | ﹤0.01% | 1646 |
|
|
2022
Q4 | $20.2M | Buy |
1,630,579
+68,486
| +4% | +$777K | ﹤0.01% | 1511 |
|
|
2022
Q3 | $16.2M | Sell |
1,562,093
-76,800
| -5% | -$871K | ﹤0.01% | 1641 |
|
|
2022
Q2 | $18.9M | Buy |
1,638,893
+17,553
| +1% | +$207K | ﹤0.01% | 1560 |
|
|
2022
Q1 | $20.4M | Sell |
1,621,340
-62,030
| -4% | -$711K | ﹤0.01% | 1659 |
|
|
2021
Q4 | $19.6M | Sell |
1,683,370
-45,513
| -3% | -$558K | ﹤0.01% | 1781 |
|
|
2021
Q3 | $22.6M | Sell |
1,728,883
-1,533
| -0.1% | -$19.8K | ﹤0.01% | 1717 |
|
|
2021
Q2 | $22.3M | Sell |
1,730,416
-124,284
| -7% | -$1.42M | ﹤0.01% | 1808 |
|
|
2021
Q1 | $20.7M | Sell |
1,854,700
-121,731
| -6% | -$1.29M | ﹤0.01% | 1800 |
|
|
2020
Q4 | $22.5M | Sell |
1,976,431
-61,818
| -3% | -$676K | ﹤0.01% | 1704 |
|
|
2020
Q3 | $18.3M | Sell |
2,038,249
-124,734
| -6% | -$1.24M | ﹤0.01% | 1702 |
|
|
2020
Q2 | $22.3M | Buy |
2,162,983
+115,445
| +6% | +$1.18M | 0.01% | 1521 |
|
|
2020
Q1 | $20.7M | Buy |
2,047,538
+46,912
| +2% | +$551K | 0.01% | 1380 |
|
|
2019
Q4 | $26.6M | Buy |
2,000,626
+43,271
| +2% | +$477K | 0.01% | 1495 |
|
|
2019
Q3 | $16.8M | Buy |
1,957,355
+169,902
| +10% | +$1.65M | ﹤0.01% | 1814 |
|
|
2019
Q2 | $19.6M | Sell |
1,787,453
-306,817
| -15% | -$3.44M | ﹤0.01% | 1708 |
|
|
2019
Q1 | $23.7M | Buy |
2,094,270
+49,988
| +2% | +$558K | 0.01% | 1543 |
|
|
2018
Q4 | $17.7M | Buy |
2,044,282
+39,410
| +2% | +$452K | 0.01% | 1678 |
|
|
2018
Q3 | $31M | Buy |
2,004,872
+44,484
| +2% | +$703K | 0.01% | 1424 |
|
|
2018
Q2 | $31.4M | Buy |
1,960,388
+95,639
| +5% | +$1.42M | 0.01% | 1402 |
|
|
2018
Q1 | $24.1M | Buy |
1,864,749
+5,508
| +0.3% | +$68.6K | 0.01% | 1540 |
|
|
2017
Q4 | $23.3M | Sell |
1,859,241
-53,645
| -3% | -$701K | 0.01% | 1591 |
|
|
2017
Q3 | $25.3M | Sell |
1,912,886
-26,490
| -1% | -$365K | 0.01% | 1543 |
|
|
2017
Q2 | $30.7M | Buy |
1,939,376
+105,626
| +6% | +$1.53M | 0.01% | 1349 |
|
|
2017
Q1 | $26.2M | Buy |
1,833,750
+30,069
| +2% | +$411K | 0.01% | 1434 |
|
|
2016
Q4 | $23.1M | Sell |
1,803,681
-304,230
| -14% | -$3.84M | 0.01% | 1501 |
|
|
2016
Q3 | $28M | Sell |
2,107,911
-3,574
| -0.2% | -$41.8K | 0.01% | 1310 |
|
|
2016
Q2 | $23.1M | Buy |
2,111,485
+34,405
| +2% | +$336K | 0.01% | 1419 |
|
|
2016
Q1 | $18.9M | Buy |
2,077,080
+36,472
| +2% | +$301K | 0.01% | 1533 |
|
|
2015
Q4 | $19.8M | Buy |
2,040,608
+44,792
| +2% | +$433K | 0.01% | 1520 |
|
|
2015
Q3 | $17.4M | Buy |
1,995,816
+82,049
| +4% | +$766K | 0.01% | 1594 |
|
|
2015
Q2 | $19.3M | Sell |
1,913,767
-23,414
| -1% | -$272K | 0.01% | 1617 |
|
|
2015
Q1 | $26M | Buy |
1,937,181
+30,158
| +2% | +$396K | 0.01% | 1369 |
|
|
2014
Q4 | $24.5M | Sell |
1,907,023
-77,847
| -4% | -$891K | 0.01% | 1376 |
|
|
2014
Q3 | $21.5M | Buy |
1,984,870
+431,924
| +28% | +$4.94M | 0.01% | 1455 |
|
|
2014
Q2 | $19.9M | Sell |
1,552,946
-511,315
| -25% | -$5.56M | 0.01% | 1522 |
|
|
2014
Q1 | $21.3M | Buy |
2,064,261
+463,491
| +29% | +$5.21M | 0.01% | 1523 |
|
|
2013
Q4 | $15.6M | Buy |
1,600,770
+22,093
| +1% | +$198K | 0.01% | 1736 |
|
|
2013
Q3 | $15.7M | Buy |
1,578,677
+102,895
| +7% | +$1.01M | 0.01% | 1671 |
|
|
2013
Q2 | $12.3M | Buy |
+1,475,782
| New | +$17.9M | ﹤0.01% | 1767 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Northern Trust's IRWD Position: Q1 2026 in Review
Northern Trust increased its Ironwood Pharmaceuticals (IRWD) stake by 2.6% in Q1 2026, buying an estimated $132K and bringing the position to 1,265,842 shares worth $4.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2523.
Northern Trust first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $31.4M in Q2 2018. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Northern Trust held 1,265,842 shares of Ironwood Pharmaceuticals worth $4.44M as of Q1 2026.
- Northern Trust bought 32,157 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $132K.
- Ironwood Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2523 holding.
- Northern Trust first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Ironwood Pharmaceuticals position peaked at $31.4M in Q2 2018.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.